BSX Q3 Earnings Top, Stock Down in Premarket as Operating Margin Falls
Boston Scientific registers year-over-year improvement in sales, indicating solid market share gains in legacy businesses despite macroeconomic odds.
| Ticker |
Sentiment |
Impact |
|
BAX
|
Neutral
|
9 %
|
|
MASI
|
Neutral
|
9 %
|
|
GMED
|
Neutral
|
9 %
|
|
BSX
|
Somewhat Bullish
|
35 %
|
